Klox Technologies has agreed to sell its professional in-office whitening kit business and teeth-whitening pen business to Valeant Pharmaceuticals International.
Financial terms include an upfront payment and a double-digit royalty stream based on product sales during the next 10 years.
Valeant is planning to launch the products in the U.S. in early 2013 through its dental affiliate, OraPharma.
%20roland%20240910.waNaqlRrsD.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.DpIowD0Qsf.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
